AI exec Reis-Filho leaves AstraZeneca for strategy role at Foresite Labs

As Foresite Labs continues its push to use AI to interrogate causal biology, the organization has brought in former AZ executive Jorge Reis-Filho as its new chief strategy officer.

Reis-Filho was chief of AI for science innovation and enterprise AI at AstraZeneca plc (LSE:AZN; NYSE:AZN). He joins a team led by co-founder and CEO Jim Tananbaum; Reis-Filho will also become an operating partner at Foresite Labs and a venture partner at Foresite Capital...